For the first time, theoretically based has been the epizootic, immunobiological and economic expediency of application of the antigenes combinations in associated vaccines against the rabbit's virus hemorrhagic disease (RVHD), mixomatosis and pasteurellosis. The novelty has been confirmed with 5 Authorized Certificates. For the first time, the technology of manufacture and the methods of control of lyophilized monovaccines and specific serum against RVHD and associated vaccines against RVHD, mixomatosis and pasteurellosis. The lyophilized tissue inactivated vaccines against RVHD have been introduced in the veterinary ptactice. The application of the developed biopreparations has allowed to sharply reduce the morbidity of rabbits in the country, to reduce the losses of animals from the RVHD, mixomatosis and pasteurellosisAvailable from VNTIC / VNTIC - Scientific & Technical Information Centre of RussiaSIGLERURussian Federatio
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.